🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate the clinical feasibility of first-line immunoch...
Status
Not Yet Recruiting
Location
The Obstetrics and Gynecology Hospital of Fudan University
Start Date
2025-03-10
Trial ID
NCT06878196
Treatments Being Tested
The purpose of this study is to determine whether intraperitoneal immunothe...
Status
Unknown
Location
Multiple Locations
Start Date
2016-12
Trial ID
NCT02976142
Treatments Being Tested
The aim of the study is to determine if intervening with combined local the...
Status
Completed
Location
Fudan Universtiy Shanghai Cancer Center
Start Date
2019-02-01
Trial ID
NCT03904927
Treatments Being Tested
Patients with intrahepatic cholangiocarcinoma (IHC) have relatively aggress...
Status
Recruiting
Location
Oslo University Hospital
Start Date
2024-02-13
Trial ID
NCT06313203
Treatments Being Tested
Approximately 40% of colorectal cancer patients will develop colorectal liv...
Status
Unknown
Location
Severance Hospital, Yonsei University Health System
Start Date
2021-11-01
Trial ID
NCT05103020
Peritoneal carcinomatosis (PC) is a well-known sequel of multiple abdominal...
Status
Completed
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT04664218
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
CCOP - Cedar Rapids Oncology Project
Start Date
1996-01
Trial ID
NCT00002716
Treatments Being Tested
The project will be pursued in our respiratory, autonomic nervous system ph...
Status
Recruiting
Location
RWTH Aachen University
Start Date
2022-05-10
Trial ID
NCT04849806
This study is a Phase 3 global, multicenter, placebo-controlled double-blin...
Status
Completed
Location
The University of Arizona Cancer Center
Start Date
2021-01-12
Trial ID
NCT04472429
Treatments Being Tested
This study is designed as an open-label, adaptive Simon Two-Stage study to ...
Status
Completed
Location
Genesis Cancer and Blood Institute
Start Date
2022-12-08
Trial ID
NCT05513742
Treatments Being Tested